Pfizer PFE
NYSE PFE
$29.57 +0.13 (+0.44%)
As of: Oct 16, 2026 · 3:59 PM EDT

Pfizer (PFE) Free Cash Flow (2009 - 2026)

Updated

Pfizer (PFE) posted Free Cash Flow of $302 million for Q2 2026, compared with -$1.2 billion a year earlier and down 86.1% from the prior quarter.

Analysis

Pfizer (PFE) Free Cash Flow (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 28, 2026, Free Cash Flow at Pfizer was $10.99 billion, down 11.7% year-over-year; for FY2025, it was $9.08 billion, down 7.7% from FY2024.

  • Annual Free Cash Flow shows a five-year compound annual growth rate of -5.7% (FY2020 to FY2025).
  • In prior years, Pfizer's Free Cash Flow was $9.84 billion in FY2024 (+105.2%), $4.79 billion in FY2023 (-81.6%), $26.03 billion in FY2022 (-13.8%) and $30.21 billion in FY2021 (+148.1%).
  • Quarterly Free Cash Flow has run from a low of -$2.42 billion in Q2 2024 to a high of $10.54 billion in Q3 2021 over five years.
  • On a year-over-year basis, Free Cash Flow increased in three of the last five quarters, with growth averaging 72.7%.
  • The strongest year-over-year quarter for Free Cash Flow in the past five years was Q3 2021, with growth of 565.7%; the weakest was Q1 2023, with a decline of 98.8%.
  • According to Business Quant data, Free Cash Flow for the three prior quarters was $2.18 billion (Q1 2026), $4.5 billion (Q4 2025) and $4 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 7.76 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 7.30 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 3.11 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 4.48 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 5.56 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 1.01 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 3.49 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 3.43 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 302.00 Mn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 1.01 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 302.00 Mn
Mar 29, 2026 2.18 Bn
Dec 31, 2025 4.50 Bn
Sep 28, 2025 4.00 Bn
Jun 29, 2025 -1.20 Bn
Mar 30, 2025 1.77 Bn
Dec 31, 2024 5.80 Bn
Sep 29, 2024 6.06 Bn
Jun 30, 2024 -2.42 Bn
Mar 31, 2024 386.00 Mn
Dec 31, 2023 4.20 Bn
Oct 1, 2023 2.65 Bn
Jul 2, 2023 -2.12 Bn
Apr 2, 2023 73.00 Mn
Dec 31, 2022 7.58 Bn
Oct 2, 2022 5.13 Bn
Jul 3, 2022 7.43 Bn
Apr 3, 2022 5.90 Bn
Dec 31, 2021 4.93 Bn
Oct 3, 2021 10.54 Bn
API Access

Pfizer Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=PFE&period=max&api_key=YOUR_API_KEY